Provided by Tiger Trade Technology Pte. Ltd.

Conmed

52.05
+0.97501.91%
Volume:119.13K
Turnover:6.19M
Market Cap:1.56B
PE:28.27
High:52.49
Open:50.90
Low:50.90
Close:51.07
52wk High:56.64
52wk Low:31.44
Shares:29.95M
Float Shares:29.86M
Volume Ratio:1.09
T/O Rate:0.40%
Dividend:0.20
Dividend Rate:0.38%
EPS(TTM):1.84
EPS(LYR):1.52
ROE:5.53%
ROA:4.14%
PB:1.50
PE(LYR):34.33

Loading ...

Conmed - Enters First Omnibus Amendment and Increased Facility Activation Notice on May 27, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 01

Board Refresh And Bylaw Changes Might Change The Case For Investing In CONMED (CNMD)

Simply Wall St.
·
May 28

BRIEF-Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors

Reuters
·
May 20

CONMED appoints Celine Martin, Jeff Mirviss to board effective July 1, 2026

Reuters
·
May 20

Conmed Corporation Appoints Celine Martin and Jeff Mirviss to Its Board of Directors

THOMSON REUTERS
·
May 20

Conmed Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 19

Conmed Corp : Bofa Global Research Cuts Price Objective to $40 From $52

THOMSON REUTERS
·
May 18

BofA Securities Adjusts CONMED Price Target to $40 From $52

MT Newswires Live
·
May 18

Is It Time To Reassess CONMED (CNMD) After Its Prolonged Share Price Slide

Simply Wall St.
·
May 10

Conmed Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 01

CONMED (CNMD) Q1 Margin Compression To 4% Tests Bullish Earnings Growth Narrative

Simply Wall St.
·
May 01

Conmed Earnings Call Balances Headwinds With Guidance

TIPRANKS
·
May 01

Conmed Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 01

Michael Matson Reiterates Hold on Conmed as Slowing Organic Growth and Margin Pressure Offset 1Q26 Beat; Price Target Raised to $35.96

TIPRANKS
·
Apr 30

Conmed reports Q1 EPS 89c, consensus 82c

TIPRANKS
·
Apr 30

Conmed backs FY26 EPS view of $4.30-$4.45, consensus $4.45

TIPRANKS
·
Apr 30

Conmed Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 30

Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance

Reuters
·
Apr 30

CONMED Q1 FY26 diluted EPS jumps to $0.45; net sales slip 1.3% to $317 million

Reuters
·
Apr 30

Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate

Benzinga Earnings
·
Apr 30